Brief digital psychological intervention to prevent relapse of non-suicidal self-injury behavior in adolescents: A randomized controlled trial / Chang ZHANG in Journal of Child Psychology and Psychiatry, 67-3 (March 2026)  

Public ISBD [article]  inJournal of Child Psychology and Psychiatry > 67-3 (March 2026) . - p.380-389 Titre : Brief digital psychological intervention to prevent relapse of non-suicidal self-injury behavior in adolescents: A randomized controlled trial Type de document : texte imprimé Auteurs : Chang ZHANG, Auteur ; Diyang QU, Auteur ; Dennis CHONG, Auteur ; Chang LEI, Auteur ; Yidong SHEN, Auteur ; Xilong CUI, Auteur ; Yuqiong HE, Auteur ; Yamin LI, Auteur ; Jianjun OU, Auteur ; Runsen CHEN, Auteur Article en page(s) : p.380-389 Langues : Anglais (eng) Mots-clés : Non-suicidal self-injury  adolescents  short message service  intervention Index. décimale : PER Périodiques Résumé : Background Non-suicidal self-injury (NSSI) poses a significant mental health challenge among adolescents, necessitating accessible and effective interventions. While the development of technology offers new opportunities, higher costs remain a concern. In this context, digital psychological interventions such as text message intervention (SMS) present a convenient and low-cost delivery method that requires no face-to-face contact. However, the extent to which this method could function as a viable strategy remains underexplored. Objective To evaluate the effectiveness of an SMS intervention specifically developed for NSSI among adolescents when combined with treatment as usual (TAU), compared to TAU alone. Methods A randomized controlled trial (RCT) was conducted with 86 Chinese adolescents, randomly assigned to either the SMS intervention plus TAU or TAU alone. The SMS intervention, consisting of text messages addressing NSSI-related knowledge, distress tolerance skills, and emotion regulation strategies, was administered over 8?weeks. Assessments were conducted at baseline, 4?weeks, and 8?weeks. Results Participants in the intervention group showed a significant reduction in NSSI behavior at 4?weeks (RR?=?0.43, p? En ligne : https://doi.org/10.1111/jcpp.70054 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=580 [article] Brief digital psychological intervention to prevent relapse of non-suicidal self-injury behavior in adolescents: A randomized controlled trial [texte imprimé] / Chang ZHANG, Auteur ; Diyang QU, Auteur ; Dennis CHONG, Auteur ; Chang LEI, Auteur ; Yidong SHEN, Auteur ; Xilong CUI, Auteur ; Yuqiong HE, Auteur ; Yamin LI, Auteur ; Jianjun OU, Auteur ; Runsen CHEN, Auteur . - p.380-389. Langues : Anglais (eng) in Journal of Child Psychology and Psychiatry > 67-3 (March 2026) . - p.380-389 Mots-clés : Non-suicidal self-injury  adolescents  short message service  intervention Index. décimale : PER Périodiques Résumé : Background Non-suicidal self-injury (NSSI) poses a significant mental health challenge among adolescents, necessitating accessible and effective interventions. While the development of technology offers new opportunities, higher costs remain a concern. In this context, digital psychological interventions such as text message intervention (SMS) present a convenient and low-cost delivery method that requires no face-to-face contact. However, the extent to which this method could function as a viable strategy remains underexplored. Objective To evaluate the effectiveness of an SMS intervention specifically developed for NSSI among adolescents when combined with treatment as usual (TAU), compared to TAU alone. Methods A randomized controlled trial (RCT) was conducted with 86 Chinese adolescents, randomly assigned to either the SMS intervention plus TAU or TAU alone. The SMS intervention, consisting of text messages addressing NSSI-related knowledge, distress tolerance skills, and emotion regulation strategies, was administered over 8?weeks. Assessments were conducted at baseline, 4?weeks, and 8?weeks. Results Participants in the intervention group showed a significant reduction in NSSI behavior at 4?weeks (RR?=?0.43, p? En ligne : https://doi.org/10.1111/jcpp.70054 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=580

Cognitive-Based Interventions for Improving Psychological Health and Well-Being for Parents of Children with Developmental Disabilities: A Systematic Review and Meta-analysis / Yijing YONG ; Yamin LI ; Jianhe LI ; Jiao XIE in Journal of Autism and Developmental Disorders, 54-9 (September 2024)  

Public ISBD [article]  inJournal of Autism and Developmental Disorders > 54-9 (September 2024) . - p.3316-3335 Titre : Cognitive-Based Interventions for Improving Psychological Health and Well-Being for Parents of Children with Developmental Disabilities: A Systematic Review and Meta-analysis Type de document : texte imprimé Auteurs : Yijing YONG, Auteur ; Yamin LI, Auteur ; Jianhe LI, Auteur ; Jiao XIE, Auteur Article en page(s) : p.3316-3335 Langues : Anglais (eng) Index. décimale : PER Périodiques Résumé : This review aims to systematically summarize existing evidence to determine the effectiveness of cognitive-based interventions (CBIs) on psychological health and well-being among parents of children with developmental disabilities (DD). Six databases were searched to identify eligible randomized controlled trials (RCTs) from their inception to April 2023. The revised Cochrane Risk of Bias tool for RCTs was applied to assess the risk of bias and the certainty of evidence was evaluated using the Grading of Recommendation, Assessment, Development and Evaluation. Meta-analyses were conducted using a random-effects model. Twenty-five RCTs involving 1915 participants were identified. The results indicated that CBIs reduced parental stress levels (Hedges'g = ? 0.69), depressive symptoms (g = ? 0.95), anxiety levels (g = ? 0.78), and parental distress (g = ? 0.29), and improved parental well-being (g = 0.62) and parent?child relationships (g = 0.43) postintervention compared with the active/inactive control groups. Subgroup analysis of the effectiveness of interventions using mindfulness-based interventions and cognitive behavioural therapy showed positive effects. The favourable intervention duration and participant targets were also identified in this review. Furthermore, the effects of CBIs were impacted by the different types of DD among the children. This review highlighted the positive effects of CBIs on parental stress levels, depressive symptoms, anxiety levels, parental distress levels, parental well-being levels, and parent?child relationships. Future well-designed RCTs are needed to further investigate the effects of MBIs and CBT interventions on children with DD and their parents, as well as the factors and mechanisms of action affecting the efficacy of these interventions. En ligne : https://doi.org/10.1007/s10803-023-06063-x Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=534 [article] Cognitive-Based Interventions for Improving Psychological Health and Well-Being for Parents of Children with Developmental Disabilities: A Systematic Review and Meta-analysis [texte imprimé] / Yijing YONG, Auteur ; Yamin LI, Auteur ; Jianhe LI, Auteur ; Jiao XIE, Auteur . - p.3316-3335. Langues : Anglais (eng) in Journal of Autism and Developmental Disorders > 54-9 (September 2024) . - p.3316-3335 Index. décimale : PER Périodiques Résumé : This review aims to systematically summarize existing evidence to determine the effectiveness of cognitive-based interventions (CBIs) on psychological health and well-being among parents of children with developmental disabilities (DD). Six databases were searched to identify eligible randomized controlled trials (RCTs) from their inception to April 2023. The revised Cochrane Risk of Bias tool for RCTs was applied to assess the risk of bias and the certainty of evidence was evaluated using the Grading of Recommendation, Assessment, Development and Evaluation. Meta-analyses were conducted using a random-effects model. Twenty-five RCTs involving 1915 participants were identified. The results indicated that CBIs reduced parental stress levels (Hedges'g = ? 0.69), depressive symptoms (g = ? 0.95), anxiety levels (g = ? 0.78), and parental distress (g = ? 0.29), and improved parental well-being (g = 0.62) and parent?child relationships (g = 0.43) postintervention compared with the active/inactive control groups. Subgroup analysis of the effectiveness of interventions using mindfulness-based interventions and cognitive behavioural therapy showed positive effects. The favourable intervention duration and participant targets were also identified in this review. Furthermore, the effects of CBIs were impacted by the different types of DD among the children. This review highlighted the positive effects of CBIs on parental stress levels, depressive symptoms, anxiety levels, parental distress levels, parental well-being levels, and parent?child relationships. Future well-designed RCTs are needed to further investigate the effects of MBIs and CBT interventions on children with DD and their parents, as well as the factors and mechanisms of action affecting the efficacy of these interventions. En ligne : https://doi.org/10.1007/s10803-023-06063-x Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=534

Efficacy of Sulforaphane in Treatment of Children with Autism Spectrum Disorder: A Randomized Double-Blind Placebo-Controlled Multi-center Trial / Robert C. SMITH ; Russell H. TOBE ; Jingjing LIN ; Jen ARRIAZA ; Jed W. FAHEY ; Ruiting LIU ; Ying ZENG ; Yanan LIU ; Lian HUANG ; Yidong SHEN ; Yamin LI ; Daomeng CHENG ; Brian CORNBLATT ; John M. DAVIS ; Jingping ZHAO ; Renrong WU ; Hua JIN in Journal of Autism and Developmental Disorders, 54-2 (February 2024)  

Public ISBD [article]  inJournal of Autism and Developmental Disorders > 54-2 (February 2024) . - p.628-641 Titre : Efficacy of Sulforaphane in Treatment of Children with Autism Spectrum Disorder: A Randomized Double-Blind Placebo-Controlled Multi-center Trial Type de document : texte imprimé Auteurs : Robert C. SMITH, Auteur ; Russell H. TOBE, Auteur ; Jingjing LIN, Auteur ; Jen ARRIAZA, Auteur ; Jed W. FAHEY, Auteur ; Ruiting LIU, Auteur ; Ying ZENG, Auteur ; Yanan LIU, Auteur ; Lian HUANG, Auteur ; Yidong SHEN, Auteur ; Yamin LI, Auteur ; Daomeng CHENG, Auteur ; Brian CORNBLATT, Auteur ; John M. DAVIS, Auteur ; Jingping ZHAO, Auteur ; Renrong WU, Auteur ; Hua JIN, Auteur Article en page(s) : p.628-641 Index. décimale : PER Périodiques Résumé : Sulforaphane has been reported to possibly improve core symptoms associated with autism spectrum disorders from mostly small size studies. Here we present results of a larger randomized clinical trial (N 108) in China. There were no significant changes in caregiver rated scales between sulforaphane and placebo groups. However, clinician rated scales showed a significant improvement in the sulforaphane group, and one third of participants showed at least a 30% decrease in score by 12 weeks treatment. The effects of sulforaphane were seen across the full range of intelligence and greater in participants over 10 years. Sulforaphane was safe and well-tolerated even for young children. The inconsistent results between caregiver and clinician rated scales suggest more clinical trials are needed to confirm our findings. En ligne : https://doi.org/10.1007/s10803-022-05784-9 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=520 [article] Efficacy of Sulforaphane in Treatment of Children with Autism Spectrum Disorder: A Randomized Double-Blind Placebo-Controlled Multi-center Trial [texte imprimé] / Robert C. SMITH, Auteur ; Russell H. TOBE, Auteur ; Jingjing LIN, Auteur ; Jen ARRIAZA, Auteur ; Jed W. FAHEY, Auteur ; Ruiting LIU, Auteur ; Ying ZENG, Auteur ; Yanan LIU, Auteur ; Lian HUANG, Auteur ; Yidong SHEN, Auteur ; Yamin LI, Auteur ; Daomeng CHENG, Auteur ; Brian CORNBLATT, Auteur ; John M. DAVIS, Auteur ; Jingping ZHAO, Auteur ; Renrong WU, Auteur ; Hua JIN, Auteur . - p.628-641. in Journal of Autism and Developmental Disorders > 54-2 (February 2024) . - p.628-641 Index. décimale : PER Périodiques Résumé : Sulforaphane has been reported to possibly improve core symptoms associated with autism spectrum disorders from mostly small size studies. Here we present results of a larger randomized clinical trial (N 108) in China. There were no significant changes in caregiver rated scales between sulforaphane and placebo groups. However, clinician rated scales showed a significant improvement in the sulforaphane group, and one third of participants showed at least a 30% decrease in score by 12 weeks treatment. The effects of sulforaphane were seen across the full range of intelligence and greater in participants over 10 years. Sulforaphane was safe and well-tolerated even for young children. The inconsistent results between caregiver and clinician rated scales suggest more clinical trials are needed to confirm our findings. En ligne : https://doi.org/10.1007/s10803-022-05784-9 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=520

---

1 (1 - 3 / 3) Par page : 25 50 100 200